Legend Biotech (NASDAQ: LEGN) reported Q3 EPS of ($0.17), $0.14 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $96.01 million versus the consensus estimate of $97.42 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.